Celecoxib as an in vivo probe of cyclooxygenase-2 mechanisms underlying retrograde amnesia in an animal model of ECT

  • Chittaranjan AndradeEmail author
  • Shivashanmugam Thyagarajan
  • Nagendra Madan Singh
  • Pabbisetty S. Vinod
  • N. Sanjay Kumar Rao
  • J. Suresh Chandra
Biological Psychiatry - Original Article



Cyclooxygenase-2 (COX-2) mechanisms are involved in glutamate-mediated learning and memory as well as in glutamatergic excitotoxicity. Electroconvulsive therapy (ECT)-induced amnesia may arise from glutamatergic excitotoxicity; if so, COX-2 inhibition may attenuate retrograde amnesia with ECT.


Wistar rats which received celecoxib (15 mg/kg per day) or vehicle for 18 days were trained for 3 days on a passive avoidance task. On each of the next 3 days, rats which showed perfect learning (n = 51) received true or sham suprathreshold electroconvulsive shocks (ECS; 60 mC) in a factorial design; daily dosing with drug or vehicle was continued. One day after the last ECS, recall of pre-ECS learning was tested.


ECS-treated rats showed impaired recall in the vehicle but not celecoxib group. Celecoxib significantly protected against ECS-induced retrograde amnesia; this benefit was independent of the drug-induced attenuation of ECS seizure duration.


Celecoxib may protect against ECS-induced retrograde amnesia by attenuating ECS-induced, COX-2-mediated glutamatergic excitotoxicity.


Electroconvulsive therapy Learning Memory Celecoxib COX-2 Glutamate 



Author S. Thyagarajan was supported by an unrestricted grant from the non-profit Scion Natural Science Association, St James, New York, USA.

Conflict of interest statement

There are no financial or other conflicts of interest except as stated in the acknowledgement.


  1. Andrade C (2005) Electroconvulsive therapy. In: Bhugra D, Ranjith G, Patel V (eds) Handbook of psychiatry: a South Asian perspective. New Delhi, Byword Publishers, pp 553–568Google Scholar
  2. Andrade C, Kurinji S, Sudha S, Chandra JS (2002a) Effects of pulse amplitude, pulse frequency, and stimulus duration on seizure threshold: a laboratory investigation. J ECT 18:144–148PubMedCrossRefGoogle Scholar
  3. Andrade C, Thyagarajan S, Vinod PS, Srikanth SN, Rao NSK, Chandra JS (2002b) Effect of stimulus intensity and number of treatments on ECS-related seizure duration and retrograde amnesia in rats. J ECT 18:197–202PubMedCrossRefGoogle Scholar
  4. Andrade C, Singh NM, Thyagarajan S, Nagaraja N, Rao NSK, Chandra JS (2007) Possible glutamatergic and lipid signalling mechanisms in ECT-induced retrograde amnesia: experimental evidence for involvement of COX-2, and review of literature. J Psychiatr Res. doi: 10.1016/j.jpsychires.2007.08.009
  5. Bazan NG, Tu B, Rodriguez de Turco EB (2002) What synaptic lipid signaling tells us about seizure-induced damage and epileptogenesis. Prog Brain Res 135:175–185PubMedCrossRefGoogle Scholar
  6. Chamberlin E, Tsai GE (1998) A glutamatergic model of ECT-induced memory dysfunction. Harv Rev Psychiatry 5:307–317PubMedCrossRefGoogle Scholar
  7. Izquierdo I, Bevilaqua LR, Rossato JI, Bonini JS, Medina JH, Cammarota M (2006) Different molecular cascades in different sites of the brain control memory consolidation. Trends Neurosci 29:496–505PubMedCrossRefGoogle Scholar
  8. Kamath S, Andrade C, Faruqi S, Venkataraman BV, Naga Rani MA, Candade VS (1997) Evaluation of pre-ECS antihypertensive drug administration in the attenuation of ECS-induced amnesia in rats. Convuls Ther 13:185–195PubMedGoogle Scholar
  9. Lerer B (1985) Studies on the role of brain cholinergic systems in the therapeutic mechanisms and adverse effects of ECT and lithium. Biol Psychiatry 20:20–40PubMedCrossRefGoogle Scholar
  10. Lerer B, Stanley M, McIntyre I, Altman H (1984) Electroconvulsive shock and brain muscarinic receptors: relationship to anterograde amnesia. Life Sci 35:2659–2664PubMedCrossRefGoogle Scholar
  11. Lipsky PE (1999) Specific COX-2 inhibitors in arthritis, oncology, and beyond: where is the science headed? J Rheumatol Suppl 56:25–30PubMedGoogle Scholar
  12. McDaniel WW, Sahota AK, Vyas BV, Laguerta N, Hategan L, Oswald J (2006) Ketamine appears associated with better word recall than etomidate after a course of 6 electroconvulsive therapies. J ECT 22:103–106PubMedCrossRefGoogle Scholar
  13. Mertensson B, Bartfai A, Hallin B, Hellstrvm C, Junthi T, Olander M (1994) A comparison of propofol and methohexital as anesthetic agents for ECT: effects on seizure duration, therapeutic outcome, and memory. Biol Psychiatry 35:179–189CrossRefGoogle Scholar
  14. Miller AL, Faber RA, Hatch JP, Alexander HE (1985) Factors affecting amnesia, seizure duration and efficacy in ECT. Am J Psychiatry 142:692–696PubMedGoogle Scholar
  15. Nagaraja N, Andrade C, Sudha S, Singh NM, Chandra JS, Venkataraman BV (2007) Glucocorticoid mechanisms may contribute to ECT-induced retrograde amnesia. Psychopharmacology (Berlin) 190:73–80CrossRefGoogle Scholar
  16. Newton SS, Collier EF, Hunsberger J, Adams D, Terwilliger R, Selvanayagam E, Duman RS (2003) Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors. J Neurosci 23:10841–10851PubMedGoogle Scholar
  17. Pigot M, Andrade C, Loo C (2007) Pharmacological attenuation of ECT-induced cognitive deficits: theoretical background and clinical findings. J ECT 24:57–67Google Scholar
  18. Rall JM, Mach SA, Dash PK (2003) Intrahippocampal infusion of a cyclooxygenase-2 inhibitor attenuates memory acquisition in rats. Brain Res 968:273–276PubMedCrossRefGoogle Scholar
  19. Rao NSK, Andrade C, Reddy KP, Madappa KN, Thyagarajan S, Chandra JS (2002) Memory protective effect of indomethacin against electroconvulsive shocks induced by retrograde amnesia in rats. Biol Psychiatry 51:770–773PubMedCrossRefGoogle Scholar
  20. Reid IC, Stewart CA (1997) Seizures, memory and synaptic plasticity. Seizure 6:351–359PubMedCrossRefGoogle Scholar
  21. Sackeim HA (1992) The cognitive effects of electroconvulsive therapy. In: Thal LJ, Moos WH, Gamzu ER (eds) Cognitive disorders: pathophysiology and treatment. New York, Marcel Dekker, pp 183–228Google Scholar
  22. Sang N, Chen C (2006) Lipid signaling and synaptic plasticity. Neuroscientist 12:425–434PubMedCrossRefGoogle Scholar
  23. Sharifzadeh M, Naghdi N, Khosrovani S, Ostad SN, Sharifzadeh K, Roghani A (2005) Post-training intrahippocampal infusion of the COX-2 inhibitor celecoxib impaired spatial memory retention in rats. Eur J Pharmacol 511:159–166PubMedCrossRefGoogle Scholar
  24. Stecher J, Müller WE, Hoyer S (1997) Learning abilities depend on NMDA-receptor density in hippocampus in adult rats. J Neural Transm 104:281–289PubMedCrossRefGoogle Scholar
  25. Stewart C, Reid I (1993) Electroconvulsive stimulation and synaptic plasticity in the rat. Brain Res 620:139–141PubMedCrossRefGoogle Scholar
  26. Stewart CA, Reid IC (1994) Ketamine prevents ECS-induced synaptic enhancement in rat hippocampus. Neurosci Lett 178:11–14. Erratum in: Neurosci Lett 1996, 210:218Google Scholar
  27. Stewart C, Jeffery K, Reid I (1994) LTP-like synaptic efficacy changes following electroconvulsive stimulation. Neuroreport 5:1041–1044PubMedCrossRefGoogle Scholar
  28. Swaim JC, Mansour M, Wydo SM, Moore JL (2006) A retrospective comparison of anesthetic agents in electroconvulsive therapy. J ECT 22:243–246PubMedCrossRefGoogle Scholar
  29. Teather LA, Packard MG, Bazan NG (2002) Post-training cyclooxygenase-2 (COX-2) inhibition impairs memory consolidation. Learn Mem 9:41–47PubMedCrossRefGoogle Scholar
  30. Wang H, Hu Y, Tsien JZ (2006) Molecular and systems mechanisms of memory consolidation and storage. Prog Neurobiol 79:123–135PubMedCrossRefGoogle Scholar
  31. Warner TD, Giuliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR (1999) Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci USA 96:7563-7568. Erratum in: Proc Natl Acad Sci USA 1999, 96:9666Google Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Chittaranjan Andrade
    • 1
    Email author
  • Shivashanmugam Thyagarajan
    • 1
  • Nagendra Madan Singh
    • 1
  • Pabbisetty S. Vinod
    • 1
  • N. Sanjay Kumar Rao
    • 2
  • J. Suresh Chandra
    • 3
  1. 1.Department of PsychopharmacologyNational Institute of Mental Health and NeurosciencesBangaloreIndia
  2. 2.Consultant Liaison Psychiatrist and Clinical Lead, The Logos Centre for Cognitive Behavioural Therapy and Mental Health PromotionTees Esk and Wear Valley NHS Trust, County HospitalDurhamUK
  3. 3.Senior Veterinarian, Central Animal Research FacilityNational Institute of Mental Health and NeurosciencesBangaloreIndia

Personalised recommendations